ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Assessing Clinical Inertia on Implementing Clinical Guideline Recommendations in Patients with Type 2 Diabetes: A Clinician Survey Study.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate how clinicians' attitudes, knowledge and treatment behavior align with American Diabetes Association (ADA) standards of care (SOC) clinical practice guidelines (CPGs). Research Design and Methods: A cross-sectional internet survey was conducted among clinicians caring for patients with type 2 diabetes who were identified from administrative claims in a large United States administrative claims database. Eligible clinicians consisted of primary care physicians, endocrinologists, physician assistants, and nurse practitioners. The survey assessed attitudes toward, knowledge of, and use of ADA CPGs related to cardiometabolic SOC. Clinicians' "real-world" use of CPGs was assessed by calculating the attainment of six therapeutic management (TM) measures using administrative claims data. TM measure attainment was defined as the proportion of eligible patients receiving guideline-concordant care and was calculated only for measures where clinicians had ≥5 eligible patients. Clinicians' survey data were linked with their TM measure attainment data for analytic purposes. Results: A total of 402 clinicians completed the survey and 314 clinicians had at least one TM measure attainment. Despite generally positive attitudes and adequate guideline knowledge, TM attainment was below 50% on four of the six TM measures and correlations between attitudes, knowledge, and TM attainment were low. Concordance/discordance analysis showed the "guideline inertia" group consisting of clinicians with high knowledge but low TM measure attainment to be the most frequently occurring group. Adoption of GLP-1 receptor agonists and SGLT2 inhibitors remained low among clinicians treating patients with comorbid ASCVD, heart failure, or chronic kidney disease. Conclusion: Clinicians demonstrated adequate knowledge of ADA SOC but showed persistent clinical inertia in translating this knowledge into cardiometabolic risk management. These findings highlight that knowledge alone is insufficient for achieving guideline-concordant prescribing behavior. Multi-level strategies incorporating clinician education, system-level support, and patient engagement may be required to improve adoption of evidence-based therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.